Amarin Corporation PLC (AMRN) Informed by FDA That October 16th Advisory Committee Meeting Will Take Place as Scheduled
10/3/2013 10:03:55 AM
BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 3, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that it was notified by the U.S. Food and Drug Administration (FDA) that the scheduled advisory committee meeting to be held on October 16, 2013 in connection with the proposed Vascepa® (icosapent ethyl) ANCHOR indication will take place as scheduled despite the current Federal Government lapse in appropriations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by